Patents by Inventor Christoph Hasenhindl

Christoph Hasenhindl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED PRODUCTION OF IMMUNOGLOBULINS
    Publication number: 20210292378
    Abstract: The present invention provides methods and compositions for generating transgenic animals, including transgenic mammals, as well as plasma cells that allow for cell surface capture of secreted immunoglobulin molecules produced endogenously in the plasma cells.
    Type: Application
    Filed: June 3, 2021
    Publication date: September 23, 2021
    Inventors: Nigel KILLEEN, Christoph HASENHINDL, Bao DUONG
  • Enhanced production of immunoglobulins
    Patent number: 11053288
    Abstract: The present invention provides methods and compositions for generating transgenic animals, including transgenic mammals, as well as plasma cells that allow for cell surface capture of secreted immunoglobulin molecules produced endogenously in the plasma cells.
    Type: Grant
    Filed: February 3, 2017
    Date of Patent: July 6, 2021
    Assignee: TRIANNI, INC.
    Inventors: Nigel Killeen, Christoph Hasenhindl, Bao Duong
  • ENHANCED PRODUCTION OF IMMUNOGLOBULINS
    Publication number: 20170226162
    Abstract: The present invention provides methods and compositions for generating transgenic animals, including transgenic mammals, as well as plasma cells that allow for cell surface capture of secreted immunoglobulin molecules produced endogenously in the plasma cells.
    Type: Application
    Filed: February 3, 2017
    Publication date: August 10, 2017
    Inventors: Nigel Killeen, Christoph Hasenhindl, Bao Duong